Authors
Loading...
Does not warrant clinical changes in hypertension management; leaves open human validation of GRK4 as therapeutic target.
Key points are not available for this paper at this time.
Wang et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: